Rauwolscine - Oxervate (Cenegermin-bkbj) Interaction
Brand names: Oxervate
Medical Content Editor Dr. Brian Staiger, PharmD
Last updated Jul 22, 2023
There were no interactions found between Cenegermin-bkbj and Rauwolscine. This does not mean the potential for an interaction does not exist, however. There is often a lack of studies and data surrounding traditional medicine, especially concerning drug interactions, so it is important to always consult your provider before making any changes to your medication regimen.
Ophthalmic cenegermin-bkbj is used to treat neurotrophic keratitis (a degenerative eye disease that can lead to damage of the cornea [the outermost layer of the eye]). Cenegermin-bkbj is in a class of medications called recombinant human nerve growth factors. It works to heal the cornea.
Rauwolscine - More Interactions
Rauwolscine interacts with 668 drugs
Interaction Rating Key
These severity listings are for informational use only. Never start, stop or otherwise change your therapy before speaking with your provider.
|Major||The combined use of these agents is strongly discouraged as serious side effects or other negative outcomes could occur.|
|Moderate||Use cautiously under the care of a healthcare professional or avoid this combination. A significant interaction or negative outcome could occur.|
|Minor||Be aware that there is a chance of an interaction. Watch for warning signs of a potential interaction.|
|Unknown||No interactions have been reported or no interaction data is currently available.|
Visit Our Drug-Herbal Interaction Checker
Popular Interaction Pages
Parts of this content are provided by the Therapeutic Research Center, LLC.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Drug descriptions are provided by MedlinePlus.